Form 4: Amedisys Inc. Executive Denise M. Bohnert Reports Stock Award and Tax Withholding
SEC Form 4 Filing
Chief Compliance Officer Denise M. Bohnert of Amedisys Inc. reports the acquisition of 5,832 restricted stock units (RSUs) and the disposal of shares for tax withholding.
Summary
- Denise M. Bohnert, Chief Compliance Officer of Amedisys Inc., filed a Form 4 detailing changes in beneficial ownership.
- On February 16, 2025, Bohnert was awarded 5,832 time-based RSUs, which will vest over three years.
- 25% of the RSUs will vest on each of February 16, 2026 and February 16, 2027 and 50% on February 16, 2028, contingent upon continued employment.
- Also on February 16, 2025, 665 shares were disposed of to cover tax obligations at a price of $92.6 per share.
- Following these transactions, Bohnert directly owns 21,010 shares of Amedisys Inc. common stock.
- Bohnert also indirectly owns 214 shares through a 401(k) plan, based on a statement dated December 31, 2024.
Sentiment
Score: 6
Explanation: The document reflects standard executive compensation practices and insider trading reporting, with no particularly positive or negative implications.
Positives
- The grant of RSUs to a key executive aligns their interests with the long-term performance of the company.
Negatives
- The disposal of shares to cover tax obligations, while common, slightly reduces the executive's direct stake in the company.
Risks
- The vesting of RSUs is contingent upon continued employment, creating a potential risk if the executive leaves the company before full vesting.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The granting of RSUs is a common method of executive compensation in the healthcare industry, aligning executive incentives with shareholder value.
Stakeholder Impact
- The RSU grant aligns executive interests with shareholder value, potentially incentivizing actions that benefit shareholders.
Key Dates
| Date | Description |
|---|---|
| 2024-12-31 | Date of 401(k) plan statement. |
| 2025-02-16 | Date of RSU award and tax withholding transaction. |
| 2026-02-16 | First vesting date for 25% of RSUs. |
| 2027-02-16 | Second vesting date for 25% of RSUs. |
| 2028-02-16 | Final vesting date for 50% of RSUs. |
| 2025-02-19 | Date of Form 4 signature. |
Keywords
Form 4, beneficial ownership, RSUs, restricted stock units, insider trading, Amedisys, Bohnert, executive compensation, stock award, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.